Back
Diebold Nixdorf 10K Form
Sell
44
DBD
Diebold Nixdorf
Last Price:
48.45
Seasonality Move:
20.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DBD News And Ratings
See the #1 stock for the next 7 days that we like better than DBD
DBD Financial Statistics
Sales & Book Value
| Annual Sales: | $3.46B |
|---|---|
| Cash Flow: | $-24.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $28.37 |
| Price / Book: | 1.71 |
Profitability
| EPS (TTM): | 0.13000 |
|---|---|
| Net Income (TTM): | $0 |
| Gross Margin: | $757.3M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Diebold Nixdorf Earnings Forecast
Key Diebold Nixdorf Financial Ratios
- The Gross Profit Margin over the past 39 years for DBD is 21.88%.
- The Selling, General & Administrative Expenses for DBD have been equal to 21.43% of Gross Profit Margin.
- The Research & Development expenses have been 3.49% of Revenue.
- The Interest Expense is -34.26% of Operating Income.
- The Net Earning history of DBD is -16.80% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 19 years.
Diebold Nixdorf Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Technology Hardware, Storage & Peripherals |
| Sector: | Information Technology |
| Current Symbol: | DBD |
| CUSIP: | 253651 |
| Website: | dieboldnixdorf.com |
Debt
| Debt-to-Equity Ratio: | 1.03 |
|---|---|
| Current Ratio: | 1.45 |
| Quick Ratio: | 0.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 9.81 |
DBD Technical Analysis vs Fundamental Analysis
Sell
44
Diebold Nixdorf (DBD)
is a Sell
Is Diebold Nixdorf a Buy or a Sell?
-
Diebold Nixdorf stock is rated a Sell
The current Diebold Nixdorf [DBD] share price is $48.41. The Score for DBD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.